— Know what they know.
Not Investment Advice

VIGL NASDAQ

Vigil Neuroscience, Inc.
1W: -0.1% 1M: +0.8% 3M: +178.6% 1Y: +100.8% 3Y: +21.1%
$8.05
Last traded 2025-08-05 — delisted
NASDAQ · Healthcare · Biotechnology · $375.7M mcap · 31M float · 5.28% daily turnover · Short 38% of daily vol

Cash Flow Trends

Operating Cash Flow
-$51M +27.2% ▲
Capital Expenditures
$5K +99.3% ▲
4Y CAGR: -68.4%
Free Cash Flow
-$51M +27.9% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$13M +90.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$4M-$43M-$68M-$83M-$84M
Depreciation & Amort.$0$28K$78K$399K$453K
Stock-Based Comp.$524$2M$5M$9M$10M
Change in Working Capital$850K$642K-$3M$3M$23M
Other Non-Cash Items-$2M$1M$932K-$125K-$155K
Operating Cash Flow-$5M-$39M-$65M-$70M-$51M
— Investing Activities —
Capital Expenditures-$500K-$204K-$921K-$674K-$5K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0-$147M-$81M
Investment Sales$0$0$0$83M$90M
Other Investing$0$0$0$0$0
Investing Cash Flow-$500K-$204K-$921K-$65M$9M
— Financing Activities —
Net Debt Issuance$5M-$38K-$43K-$23K$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0-$2M$21M$0$138K
Financing Cash Flow$30M$108M$161M$888K$29M
Net Change in Cash$24M$68M$95M-$135M-$13M
Cash End of Period$24M$92M$188M$52M$40M
Free Cash Flow-$6M-$40M-$66M-$71M-$51M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms